Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 955, pseudogene (RNU6-955P), is a human pseudogene classified as a small nuclear RNA (snRNA) pseudogene[1][6][7]. Pseudogenes such as RNU6-955P are DNA sequences resembling known genes but are generally considered nonfunctional at the protein-coding level and do not produce a functional protein product[2][6]. While a minority of pseudogenes have been shown to produce noncoding RNA transcripts affecting regulatory networks—such as acting as decoys for miRNAs or modulating parental gene expression—there are no studies specifically implicating RNU6-955P in these functions[2]. It is not considered a therapeutic target, and no drugs or clinical biomarkers are associated with this gene. The gene is formally recognized and named by the HUGO Gene Nomenclature Committee (HGNC ID: 47918)[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 955, pseudogene (RNU6-955P).